A significant shift in Canadian drug policy has occurred, as the government permit the availability of psilocybin mushrooms for therapeutic treatment. Previously, these substances were heavily restricted, but a mounting body of research suggests they may offer aid for emotional issues like anxiety. The new policy represents a major step toward re-e